BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID
Discussion in 'Long Covid news' started by RaviHVJ, Apr 29, 2024.
Discussion in 'Long Covid news' started by RaviHVJ, Apr 29, 2024.